1. Home
  2. SHMD vs AVTX Comparison

SHMD vs AVTX Comparison

Compare SHMD & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHMD
  • AVTX
  • Stock Information
  • Founded
  • SHMD 1864
  • AVTX 2011
  • Country
  • SHMD Germany
  • AVTX United States
  • Employees
  • SHMD N/A
  • AVTX N/A
  • Industry
  • SHMD
  • AVTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SHMD
  • AVTX Health Care
  • Exchange
  • SHMD Nasdaq
  • AVTX Nasdaq
  • Market Cap
  • SHMD 86.1M
  • AVTX 88.4M
  • IPO Year
  • SHMD N/A
  • AVTX 2015
  • Fundamental
  • Price
  • SHMD $2.99
  • AVTX $7.68
  • Analyst Decision
  • SHMD
  • AVTX Strong Buy
  • Analyst Count
  • SHMD 0
  • AVTX 4
  • Target Price
  • SHMD N/A
  • AVTX $33.00
  • AVG Volume (30 Days)
  • SHMD 57.5K
  • AVTX 60.0K
  • Earning Date
  • SHMD 02-25-2025
  • AVTX 03-28-2025
  • Dividend Yield
  • SHMD N/A
  • AVTX N/A
  • EPS Growth
  • SHMD 1309.32
  • AVTX N/A
  • EPS
  • SHMD 1.07
  • AVTX N/A
  • Revenue
  • SHMD $99,752,404.00
  • AVTX $820,000.00
  • Revenue This Year
  • SHMD N/A
  • AVTX N/A
  • Revenue Next Year
  • SHMD N/A
  • AVTX N/A
  • P/E Ratio
  • SHMD $2.41
  • AVTX N/A
  • Revenue Growth
  • SHMD N/A
  • AVTX N/A
  • 52 Week Low
  • SHMD $1.86
  • AVTX $4.18
  • 52 Week High
  • SHMD $6.13
  • AVTX $34.46
  • Technical
  • Relative Strength Index (RSI)
  • SHMD N/A
  • AVTX 46.68
  • Support Level
  • SHMD N/A
  • AVTX $7.79
  • Resistance Level
  • SHMD N/A
  • AVTX $8.50
  • Average True Range (ATR)
  • SHMD 0.00
  • AVTX 0.70
  • MACD
  • SHMD 0.00
  • AVTX 0.08
  • Stochastic Oscillator
  • SHMD 0.00
  • AVTX 36.04

About SHMD SCHMID Group N.V. Class A Ordinary Shares

Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

Share on Social Networks: